Recurrent palmoplantar hidradenitis
Recurrent Palmoplantar Hidradenitis (RPH) is a rare, chronic skin condition that primarily affects the palms of the hands and soles of the feet. It is characterized by painful, recurrent nodules and abscesses that can lead to significant discomfort and disability.
Overview[edit | edit source]
Recurrent Palmoplantar Hidradenitis (RPH) is a type of hidradenitis suppurativa, a chronic skin condition characterized by recurrent, painful, inflamed nodules and abscesses. RPH specifically affects the sweat glands (hidradenitis) in the palms of the hands and soles of the feet (palmoplantar). The condition is also known as Idiopathic Palmoplantar Hidradenitis, Palmoplantar Eccrine Hidradenitis, and Neutrophilic Eccrine Hidradenitis.
Symptoms[edit | edit source]
The primary symptom of RPH is the recurrent formation of painful nodules and abscesses on the palms and soles. These lesions can be extremely painful, often making it difficult for the individual to walk or use their hands. Other symptoms may include fever, malaise, and in severe cases, secondary bacterial infections.
Causes[edit | edit source]
The exact cause of RPH is unknown. However, it is believed to be related to an abnormal immune response to the sweat glands in the palms and soles. Some researchers suggest that it may be triggered by factors such as stress, hormonal changes, or certain medications.
Diagnosis[edit | edit source]
Diagnosis of RPH is primarily based on the clinical presentation of the symptoms. A skin biopsy may be performed to confirm the diagnosis and rule out other conditions.
Treatment[edit | edit source]
Treatment for RPH primarily involves managing the symptoms and preventing complications. This may include pain management, wound care, and in some cases, surgical intervention.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD